Search research articles
Contact Us
Filters
Showing results (501-510 of 598) with videos related to
Page
of 60
Sort By:
Urologic Oncology
|
January 13, 2011
Comparative studies of prostate cancers among United States, Chinese, and Japanese patients: characterization of histopathology, tumor angiogenesis, neuroendocrine factors, and p53 protein accumulations
H E Zhau, L S Zhao, L W Chung, et al.
Scientific Reports
|
January 4, 2017
CTCF interacts with the lytic HSV-1 genome to promote viral transcription
Fengchao Lang, Xin Li, Olga Vladimirova, et al.
Breast Cancer Research : BCR
|
September 25, 2013
Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers
Giampaolo Bianchini, Lajos Pusztai, Thomas Karn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2005
Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer
Roman Rouzier, Lajos Pusztai, Suzette Delaloge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors
Lajos Pusztai, Mark Ayers, James Stec, et al.
Clinical Pharmacology and Therapeutics
|
February 1, 2018
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy
Matthew P Goetz, Katrin Sangkuhl, Henk-Jan Guchelaar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2010
Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer
Adel Tabchy, Vicente Valero, Tatiana Vidaurre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 25, 2016
Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer
Kelly K Hunt, Cansu Karakas, Min Jin Ha, et al.
NPJ Breast Cancer
|
August 21, 2024
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502
Daniel G Stover, Roberto Salgado, Oleksander Savenkov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2006
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
Kenneth R Hess, Keith Anderson, W Fraser Symmans, et al.
Page
of 60
Search research articles
Search
Showing results (501-510 of 598) with videos related to
Sort By:
Page
of 60
Urologic Oncology
|
January 13, 2011
Comparative studies of prostate cancers among United States, Chinese, and Japanese patients: characterization of histopathology, tumor angiogenesis, neuroendocrine factors, and p53 protein accumulations
H E Zhau, L S Zhao, L W Chung, et al.
Scientific Reports
|
January 4, 2017
CTCF interacts with the lytic HSV-1 genome to promote viral transcription
Fengchao Lang, Xin Li, Olga Vladimirova, et al.
Breast Cancer Research : BCR
|
September 25, 2013
Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers
Giampaolo Bianchini, Lajos Pusztai, Thomas Karn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2005
Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer
Roman Rouzier, Lajos Pusztai, Suzette Delaloge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors
Lajos Pusztai, Mark Ayers, James Stec, et al.
Clinical Pharmacology and Therapeutics
|
February 1, 2018
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy
Matthew P Goetz, Katrin Sangkuhl, Henk-Jan Guchelaar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2010
Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer
Adel Tabchy, Vicente Valero, Tatiana Vidaurre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 25, 2016
Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer
Kelly K Hunt, Cansu Karakas, Min Jin Ha, et al.
NPJ Breast Cancer
|
August 21, 2024
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502
Daniel G Stover, Roberto Salgado, Oleksander Savenkov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2006
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
Kenneth R Hess, Keith Anderson, W Fraser Symmans, et al.
Page
of 60